Daiwa Securities Group
PRAX icon

Daiwa Securities Group’s Praxis Precision Medicines PRAX Stock Holding History

Daiwa Securities Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Buy
1,151
+205
+22% +$64.9K ﹤0.01% 1009
2026
Q1 		$305K Buy
946
+874
+1,214% +$270K ﹤0.01% 983
2025
Q4 		$21K Buy
72
+10
+16% +$1.86K ﹤0.01% 1158
2025
Q3 		$3K Hold
62
– – ﹤0.01% 1246
2025
Q2 		$3K Hold
62
– – ﹤0.01% 1196
2025
Q1 		$2K Hold
62
– – ﹤0.01% 1190
2024
Q4 		$5K Buy
+62
New +$4.49K ﹤0.01% 1166
2022
Q4 		– Sell
-9
Closed – – 1366
2022
Q3 		$0 Hold
9
– – ﹤0.01% 1377
2022
Q2 		$0 Hold
9
– – ﹤0.01% 1410
2022
Q1 		$1K Hold
9
– – ﹤0.01% 1329
2021
Q4 		$3K Buy
+9
New +$2.64K ﹤0.01% 1254

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Daiwa Securities Group's PRAX Position: Q2 2026 in Review

Daiwa Securities Group increased its Praxis Precision Medicines (PRAX) stake by 22% in Q2 2026, buying an estimated $64.9K and bringing the position to 1,151 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #1009.

Daiwa Securities Group first reported a position in PRAX in Q4 2021 and has held it in 11 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Daiwa Securities Group held 1,151 shares of Praxis Precision Medicines worth $385K as of Q2 2026.
  • Daiwa Securities Group bought 205 Praxis Precision Medicines shares in Q2 2026, an estimated $64.9K.
  • Praxis Precision Medicines made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #1009 holding.
  • Daiwa Securities Group first reported a position in Praxis Precision Medicines in Q4 2021 and has held it in 11 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.